The global insulin aspart market is gaining steady momentum as the worldwide burden of diabetes continues to increase. Rising obesity levels, sedentary lifestyles, aging populations, and improving diagnosis rates are expanding the number of patients requiring effective insulin-based therapies. As a rapid-acting insulin analog, insulin aspart plays an important role in mealtime glucose...